textabstractBACKGROUND: Screening for prostate cancer advances the time of diagnosis (lead time) and detects cancers that would not have been diagnosed in the absence of screening (overdetection). Both consequences have considerable impact on the net benefits of screening. METHODS: We developed simulation models based on results of the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (ERSPC), which enrolled 42,376 men and in which 1498 cases of prostate cancer were identified, and on baseline prostate cancer incidence and stage distribution data. The models were used to predict mean lead times, overdetection rates, and ranges (corresponding to approxima...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) has shown to reduce prost...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
textabstractBackground The time by which prostate-specific antigen (PSA) screening advances prostate...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
textabstractBackground:Prostate cancer screening with prostate-specific antigen (PSA) has shown to r...
textabstractBackground: The incidence of prostate cancer has increased substantially since it became...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) has shown to reduce prost...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
Background: Screening for prostate cancer advances the time of diagnosis (lead time) and detects can...
textabstractBackground The time by which prostate-specific antigen (PSA) screening advances prostate...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background: Lead-time is defined as the time by which screening advances the diagnosis compared with...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
Background The time by which prostate-specific antigen (PSA) screening advances prostate cancer diag...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
BACKGROUND: Lead time, the estimated time by which screening advances the date of diagnosis, is used...
textabstractBackground:Prostate cancer screening with prostate-specific antigen (PSA) has shown to r...
textabstractBackground: The incidence of prostate cancer has increased substantially since it became...
textabstractBackground: Prostate cancer screening depends on a careful balance of benefits, in terms...
BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) has shown to reduce prost...
Screening serum levels of prostate-specific antigen (PSA) is now a major strategy for early detectio...